Our project was to embed a specialist pharmacist into the Gastroenterology team to switch patients from biologics to biosimilars.
As these are high cost drugs usually funded via the CCG, the post was part funded by the CCG with the cost savings from the switch splitequally between the PAH & the CCG.
In addition, we planned to initiate pharmacist-led immunosuppression clinics to free up consultant time as well as streamlining shared care communication between the Trust and GPs.
